Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.
A. Jonas Ekstrand, Noriaki Sugawa, Charles David James et al. · Proceedings of the National Academy of Sciences · 1992
This study describes genomic rearrangements near the 3' end of the epidermal growth factor receptor (EGFR) gene in eight glioblastomas displaying coamplification and expression of both normal and rearranged EGFR. In four of these cases, it was possible by PCR to amplify tumor EGFR cDNA, which allowed sequence determination of the 3' transcript alterations associated with the rearrangements. Such analysis revealed that the four cases have in common a deletion of 255 bases that encode a portion of the receptor's cytoplasmic domain. The remaining four cases revealed genomic rearrangements in the same region of the gene as those described above and revealed aberrant EGFR transcripts lacking the same 255 bases determined to be missing in the sequenced EGFR cDNAs as well as large regions of contiguous downstream sequences. Therefore, all of the eight cases described here express transcripts that do not encode large C-terminal, intracellular portions of the receptor. In three of the eight cases, the EGFR transcripts displaying a 3' alteration also displayed a 5' inframe deletion of sequences encoding a portion of the extracellular domain, and for one of the corresponding patients it was possible to determine that the two transcript alterations were acquired as separate events. We have now detected the 5' and/or 3' alterations in 21 of 32 cases of glioblastoma with EGFR amplification; no genetic alterations have been detected in glioblastomas without EGFR amplification. In combination with previously published reports, these data suggest the in vivo evolution of EGFR toward an increasingly oncogenic potential through gene amplification with subsequent and successive gene alterations.
Cited by 602 works. doi:10.1073/pnas.89.10.4309
Authors
References
- Signal transduction by receptors with tyrosine kinase activity
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
- Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin
- A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
- Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications
- Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells
- mRNA phenotyping by enzymatic amplification of randomly primed cDNA
- Epidermal-Growth-Factor-Dependent Transformation by a Human EGF Receptor Proto-Oncogene